Metagenomi, Inc. ( ($MGX) ) has released its Q2 earnings. Here is a breakdown of the information Metagenomi, Inc. presented to its investors.

Metagenomi (MGX) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.68. This compares to a loss of $0.29 per share a year ago. These figures are ...

Metagenomi Inc. MGX) on Tuesday reported a loss of $19.9 million in its second quarter.

In May 2025, the Company reported additional long-term data from its nonhuman primate (“NHP”) study that demonstrated durable and consistent FVIII activity levels through approximately 19 months. Mean ...

(Nasdaq: MGX) (the “Company”), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced the ...

Donald Trump–backed DeFi project World Liberty Financial (WLFI) aims to establish a $1.5 billion crypto treasury firm.

Tech companies are racing to build powerful data centers across the nation, especially as President Trump calls for increased ...

SoftBank's ambitious $500 billion "Stargate" AI project with OpenAI is facing delays as securing consensus among partners ...

SoftBank Group Corp. said it’s taking longer than anticipated to get Stargate off the ground, conceding for the first time ...